Search Results for "Recall Promus Heart Stent"

11:42 EDT 6th July 2015 | BioPortfolio

Matching Channels

BioMimics 3D™ Stent

Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Aorfix

Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Heart Transplantation

Heart Failure HF

Matching News

Heart: Electronic stent to provide feedback and therapy, then dissolve

Every year, an estimated half-million Americans undergo surgery to have a stent prop open a coronary artery narrowed by plaque. But sometimes the mesh tubes get clogged. Scientists have now developed ...

FDA labels Heartware's heart pump recall as Class I

A recall involving Heartware's HVAD heart pump has been categorized by the FDA as Class I.  -More- 

FDA labels Maquet's cardiac closure device recall as Class I

A recall involving Maquet Cardiovascular's TigerPaw II, a device intended to occlude the left atrial appendage of the heart t -More- 

Causes, assessment, and treatment of stent thrombosis—intravascular imaging insights

Stent thrombosis is a rare, but serious, complication of percutaneous coronary intervention and is associated with severe morbidity and mortality. In this Review, Ong and Jang discuss the use of intra...

Low stent thrombosis rates with primary PCI, regardless of antithrombotic choice

(EuroPCR) Stent thrombosis following urgent angioplasty for acute heart attack occurred in less than 1 percent of patients in a large, 'real-world' registry, regardless of whether the antithrombotic t...

Half of heart stent patients don’t follow oral antiplatelet therapy regime as prescribed

A recent survey has found that 52% of 275 ACS patients who were currently taking an oral antiplatelet have missed taking or changed the way they take it... The post Half of heart stent patients don...

Heart Treatment without Invasive Procedures Reaches Albertans

Heart Fit Clinic introduces External Counterpulsation therapy. This evidence-based, safe, and non-surgical option for patients with heart disease is now available in Calgary. Calgary, AB (PRWEB) Febru...

Putting the Squeeze on Heart Disease with ECP

Heart Fit Clinic introduces External Counterpulsation, a safe, evidence-based, and non-surgical heart disease treatment for the people of Calgary. Calgary, AB (PRWEB) March 10, 2015 External Counterp...

Matching PubMed Articles

Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial (TWENTE II).

This study assessed clinical events and patient-reported chest pain 2 years after treatment of all-comers with Resolute Integrity zotarolimus-eluting stents (Medtronic Vascular, Santa Rosa, California...

Neoatherosclerosis causing edge in-stent restenosis: optical coherence tomography findings.

A patient presenting with 'edge' in-stent restenosis 12 years after the implantation of a bare-metal stent in the mid-left anterior descending coronary artery is described. Optical coherence tomograph...

Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis.

The aim of the present study was to evaluate the natural course of acute incomplete stent apposition (ISA) after second-generation everolimus-eluting stent (EES) when compared with first-generation si...

PLATINUM China: A prospective, randomized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesions.

Objectives: The PLATINUM China clinical trial evaluated the safety and effectiveness of the thin-strut, everolimus-eluting, platinum-chromium PROMUS™ Element™ stent (PtCr-EES) (Boston Scientific, ...

Drug recall: An incubus for pharmaceutical companies and most serious drug recall of history.

There has been an increasing trend in the number of prescribed and over-the-counter drug recall over the last few years. The recall is usually due to company's discovery, customer's complaint or Food ...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement